PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-10-28 ms7000001333434320 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：中药单体;中药毒性
经验分享：9.26 提交
10.05With Editor
10.06under review
10.11为止有5个审稿人接受邀请
10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？

76 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-10-28 江城鱼儿来自上海

审稿速度:12.0 | 投稿命中率:50.0
经验分享：Under Editor Assessment半个月了。

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2023-01-04 ms5000001894093922 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：中药单体;药理机制
经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下：
* 11.08 submit
* 11.11 改格式
* 11.14 under editor assessment
* 11.15 reviewer invited + under review
* 12.15 revise
* 12.31 revise submit + with editor
* 01.01 under editor assessment
* 01.03 under review
* 01.04 accept

144 25

展开25条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-12-21 艾而文七来自湖北省

想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊..

9 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-12-16 ms2000000209612868 来自安徽省

请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-12-16 ms2000000209612868 来自安徽省

请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-10-14 ms1000001788822122 来自上海

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：中药
经验分享：今年2月份投稿
今天想给大家分享一下比较重要的几个问题：
1.阳性对照，这个是编辑要求的
2.动物实验至少2个浓度，伦理要求比较高
3.编辑要求wb要求内参和目的条带同一张膜

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-12-06 好小豆来自重庆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：中药单体
经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？

19 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-12-10 ms1000000907051820 来自河南省

偏重的研究方向：中药单体
经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2233745, encodeId=fa6f2233e45ac, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;中药毒性 经验分享：9.26 提交 10.05With Editor 10.06under review 10.11为止有5个审稿人接受邀请 10.16审回一个，然后到目前10.28没动静了。。。外审需要多长时间啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13d9456646, createdName=ms7000001333434320, createdTime=Mon Oct 28 19:18:42 CST 2024, time=2024-10-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233712, encodeId=b5872233e1287, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：Under Editor Assessment半个月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7ed1735775, createdName=江城鱼儿, createdTime=Mon Oct 28 17:03:41 CST 2024, time=2024-10-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理机制 经验分享：终于轮到我来分享经验l！这次投稿意料之外的快，可能是方向比较符合编辑的胃口，只送了一次外审，修回后就接收了，整个投稿流程也非常顺利，具体时间如下： * 11.08 submit * 11.11 改格式 * 11.14 under editor assessment * 11.15 reviewer invited + under review * 12.15 revise * 12.31 revise submit + with editor * 01.01 under editor assessment * 01.03 under review * 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2243990, encodeId=df19224399004, content=想问一下，投稿快四个月了，状态显示Reviewer invited，这速度正常嘛，真服了，去年投的没有这么慢啊.., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40b8399746, createdName=艾而文七, createdTime=Sat Dec 21 09:57:55 CST 2024, time=2024-12-21, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2242923, encodeId=42c222429234e, content=请问大家修稿意见需要两个浓度的动物实验，大家都是怎么解决的呀有没有补的么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:19:02 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2242916, encodeId=4b32224291640, content=请问大佬们，修稿意见中需要两个浓度的动物实验，大家都是怎么解决的？直接补的么？有没有不补的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b6a6535064, createdName=ms2000000209612868, createdTime=Mon Dec 16 15:07:16 CST 2024, time=2024-12-16, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：中药 经验分享：今年2月份投稿 今天想给大家分享一下比较重要的几个问题： 1.阳性对照，这个是编辑要求的 2.动物实验至少2个浓度，伦理要求比较高 3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241108, encodeId=b319224110827, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：中药单体 经验分享：文章经过几轮修改之后，应该搞得差不多了。但是编辑今天给发了这个“Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here: https://www.elsevier.com/authors/author-services/data-visualization to find out about available data visualization options and how to include them with your article”，进入这个链接显示页面不存在。请问投稿的大佬们，你们遇到过这个没？后来怎么解决得呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/17AA747B23176284716A8FACB769EF9A/100, createdBy=188f2323279, createdName=好小豆, createdTime=Fri Dec 06 15:45:37 CST 2024, time=2024-12-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2241753, encodeId=f0a92241e530f, content=偏重的研究方向：中药单体 经验分享：记录一下全过程。 7月15号投稿 7月19号编辑部处理 7月26号 Under review 10月5号一审意见出来，Revise(意见不多，差不多是minor revision)，给了3周时间 10月26号修回，因为外出开会耽误了不少时间，赶在最后一天在系统提交回复 10月28号，编辑部开始处理 11月8号二审意见回来，1号审稿人提了2个小问题，2和3号审稿人同意接收，给了2周期间修改 11月18日系统提交二审回复 11月30号编辑部开始处理 12月1号 DIP 12月2号 Editor同意接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Tue Dec 10 23:52:26 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2237551, encodeId=9648223e55110, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：第一次外审，DIP半个月了，很焦虑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220703/ac30326af85e40a198bd59fb829e58e1/640aec889c7a46399361ab5ac03a87e9.jpg, createdBy=720f2366630, createdName=待我慢慢, createdTime=Mon Nov 18 10:57:35 CST 2024, time=2024-11-18, status=1, ipAttribution=四川省)]

2024-11-18 待我慢慢来自四川省

审稿速度:1.0 | 投稿命中率:5.0
经验分享：第一次外审，DIP半个月了，很焦虑

37 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务